Health Condition 1: K746- Other and unspecified cirrhosis ofliver
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All adult patients undergoing living donor liver transplant at our institute.
Exclusion criteria
Exclusion criteria: 1)Acute liver failure patients, Acute on chronic liver failure patients 2) Pediatric patients 3)Retransplantation in a patient previously randomized in this trial 4) Without informed consent 5) Patients with known coagulation factor deficiencies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total PRBCs transfused between two groups.Timepoint: Baseline, dissection phase, anhepatic phase, post reperfusion and postoperative day 1 ,2 and 3 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 To compare the amount of FFP,Cryoprecipitate & platelets transfused between both groups 2.To compare the changes in coagulation during different stages of liver transplant between the two groups 3. To compare the duration of mechanical ventilationTimepoint: Baseline Dissection phase Anhepatic phase Post reperfusion Postoperative day 1, 2 & 3 | — |
Countries
India
Contacts
Institute Of Liver and Biliary Sciences (ILBS)